233 related articles for article (PubMed ID: 2364784)
21. [Allogeneic bone marrow transplantation in chronic myeloid leukemia. The clinical results and risk factors in 70 patients].
Tomás JF; Peñarrubia MJ; García JA; Figuera A; Gómez-García de Soria V; Steegmann JL; Arranz R; Cámara R; Gabriel R; Vázquez L
Med Clin (Barc); 1995 Nov; 105(16):605-11. PubMed ID: 8523939
[TBL] [Abstract][Full Text] [Related]
22. Cyclosporin-A in allogeneic bone marrow transplantation for leukemia: Basle experience 1979 to 1984.
Gratwohl A
Tokai J Exp Clin Med; 1985 Jun; 10(2-3):127-32. PubMed ID: 3914737
[TBL] [Abstract][Full Text] [Related]
23. Unexplained effusions: association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease.
Pretnar J; Cernelc P; Mlakar U; Fortuna M
Bone Marrow Transplant; 1996 Oct; 18(4):826. PubMed ID: 8899209
[No Abstract] [Full Text] [Related]
24. Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia.
Rondón G; Giralt S; Huh Y; Khouri I; Andersson B; Andreeff M; Champlin R
Bone Marrow Transplant; 1996 Sep; 18(3):669-72. PubMed ID: 8879640
[TBL] [Abstract][Full Text] [Related]
25. Bullous pemphigoid associated with acute graft-versus-host disease after allogeneic bone marrow transplantation.
Delbaldo C; Rieckhoff-Cantoni L; Helg C; Saurat JH
Bone Marrow Transplant; 1992 Oct; 10(4):377-9. PubMed ID: 1422495
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous allografting and autografting of skin for ulcers in a bone marrow transplant patient.
Kamei Y; Torii S; Hasegawa M; Toriyama K; Kodera Y
Transplantation; 1993 Dec; 56(6):1530-1. PubMed ID: 8279030
[No Abstract] [Full Text] [Related]
27. Allogeneic bone marrow transplantation for chronic myeloid leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Hermans J
Bone Marrow Transplant; 1996 May; 17 Suppl 3():S7-9. PubMed ID: 8769691
[TBL] [Abstract][Full Text] [Related]
28. Reciprocal bone marrow transplantation between brother and sister.
Rana I; Pinto RM; Caniglia M; Lombardi A; De Rossi G
Bone Marrow Transplant; 2002 Apr; 29(8):705-7. PubMed ID: 12180117
[TBL] [Abstract][Full Text] [Related]
29. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.
Mehta J; Powles R; Singhal S; Iveson T; Treleaven J; Catovsky D
Bone Marrow Transplant; 1996 Mar; 17(3):371-5. PubMed ID: 8704689
[TBL] [Abstract][Full Text] [Related]
30. Chronic Ulcer by Cutaneous GvHD After Bone Marrow Transplantation Treated With Skin Allograft From HLA-Identical Donor: Case Report and Literature Review.
Amendola F; Gazzola R; Lombardo M; Caminiti R; Dagna L; Baruffaldi-Preis FW
Int J Low Extrem Wounds; 2016 Jun; 15(2):139-41. PubMed ID: 27009789
[TBL] [Abstract][Full Text] [Related]
31. [Pulmonary disease as the chief manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation].
Ohtaka M; Suzuki A; Gotoh A; Nagasu M; Torii Y; Kimura Y; Ichinose Y; Toyama K; Serizawa H; Ebihara Y
Rinsho Ketsueki; 1993 Feb; 34(2):153-8. PubMed ID: 8492413
[TBL] [Abstract][Full Text] [Related]
32. [Aggressive ulcerous stomatitis due to the herpes simplex virus in an allogeneic bone marrow transplant. A clinical case].
Marinone MG; Paganelli C; Ferremi P; Rossi G; Izzi T
Minerva Stomatol; 1991; 40(7-8):499-503. PubMed ID: 1753931
[TBL] [Abstract][Full Text] [Related]
33. Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation.
Karwacka E; Ołdakowska-Jedynak U; Brydak-Godowska J; Paczek L; Kecik D
Transplant Proc; 2006; 38(1):292-4. PubMed ID: 16504728
[TBL] [Abstract][Full Text] [Related]
34. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: a focus on the incidence of graft-vs.-host disease and relapse.
Ustün C; Arslan O; Beksaç M; Koç H; Gürman G; Ozçelik T; Yilmaz B; Ilhan O; Akan H; Ozcan M; Demirer T; Uysal A; Konuk N; Arat M; Dilek I; Celebi H; Coskun HS
Biol Blood Marrow Transplant; 1999; 5(1):28-35. PubMed ID: 10232738
[TBL] [Abstract][Full Text] [Related]
35. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
[TBL] [Abstract][Full Text] [Related]
36. [Eradication of adult T-cell leukemia cells and maintenance of remission by the graft-versus-leukemia effect after allogeneic bone marrow transplantation].
Ota K; Hashino S; Shimizu K; Yonezumi M; Chiba K; Kondo T; Suzuki S; Imamura M; Asaka M
Rinsho Ketsueki; 2004 Sep; 45(9):1044-7. PubMed ID: 15510833
[TBL] [Abstract][Full Text] [Related]
37. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
[TBL] [Abstract][Full Text] [Related]
38. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.
Mehta J; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Middleton G; Eisen T; Singhal S
Bone Marrow Transplant; 1996 Oct; 18(4):741-6. PubMed ID: 8899189
[TBL] [Abstract][Full Text] [Related]
39. Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.
Michallet M; Perrin MC; Belhabri A; Molina L; Nicolini F; Tigaud JD; Sotto JJ; Guyotat D; Fière D; Archimbaud E
Bone Marrow Transplant; 1999 Jan; 23(2):145-50. PubMed ID: 10197799
[TBL] [Abstract][Full Text] [Related]
40. Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML.
Schleuning M; Günther W; Tischer J; Ledderose G; Kolb HJ
Bone Marrow Transplant; 2003 Aug; 32(3):243-50. PubMed ID: 12858194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
